Cited by 1,438Gut microbiota and healthAdipokines, Inflammation, and Metabolic DiseasesOral microbiology and periodontitis research

Impact of the gut microbiota on inflammation, obesity, and metabolic disease

Open access
Boulangé, Claire L., Neves, Ana Luisa, Chilloux, Julien, Nicholson, Jeremy K., Dumas, Marc-Emmanuel·2016·Genome Medicine

Abstract

The human gut harbors more than 100 trillion microbial cells, which have an essential role in human metabolic regulation via their symbiotic interactions with the host. Altered gut microbial ecosystems have been associated with increased metabolic and immune disorders in animals and humans. Molecular interactions linking the gut microbiota with host energy metabolism, lipid accumulation, and immunity have also been identified. However, the exact mechanisms that link specific variations in the composition of the gut microbiota with the development of obesity and metabolic diseases in humans remain obscure owing to the complex etiology of these pathologies. In this review, we discuss current knowledge about the mechanistic interactions between the gut microbiota, host energy metabolism, and the host immune system in the context of obesity and metabolic disease, with a focus on the importance of the axis that links gut microbes and host metabolic inflammation. Finally, we discuss therapeutic approaches aimed at reshaping the gut microbial ecosystem to regulate obesity and related pathologies, as well as the challenges that remain in this area.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13073-016-0303-2

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Changes in the aging intestinal microbiota can adversely affect host metabolism and immunity and are associated with development of cardiovascular, autoimmune, metabolic, and neurodegenerative disorders.

    “These changes can adversely affect the host metabolism and immunity [25–27, 40, 64, 86, 110, 112, 118] and are associated with the development of cardiovascular, autoimmune, metabolic, and neurodegenerative disorders [17, 90, 122, 132].”
  • Dysbiosis has been linked to obesity, diabetes mellitus, and inflammatory bowel disease, and altering the microbiome may treat these conditions.

    “Alterations of the microbiome, known as dysbiosis, have also been shown to be related to obesity, diabetes mellitus and inflammatory bowel disease64, and manipulation of the microbiome may be a pathway to treating these pathological conditions.”

    From Clinical metagenomics (2019) · cites this paper as [64]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Boulangé, C. L., Neves, A. L., Chilloux, J., Nicholson, J. K., & Dumas, M.-E.
Affiliations
Imperial College London (GB)
Corresponding author
  • Nicholson, Jeremy K.
  • Dumas, Marc-Emmanuel
Venue
Genome Medicine
Published
2016-04-20
Volume
8
Issue
1
Pages
42-42
ISSN
1756-994X (ISSN-L)
OpenAlex
W2339765445
Cited by
1,438
References
111
Citations by year
2026: 89 · 2025: 153 · 2024: 169 · 2023: 146 · 2022: 156 · 2021: 202 · 2020: 156 · 2019: 150 · 2018: 126 · 2017: 74 · 2016: 14 · 2014: 1
FWCI
10.96
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Genome Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
  • Nestlé (RDLS015375)
  • Portuguese Foundation for Science and Technology (SFRH/BD/52036/2012)
  • Seventh Framework Programme (BE) (HEALTH-F4-2012-305312, 291840)
  • Medical Research Council (GB) (MR/M501797/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
Keywords
gut microbiota, obesity, metabolic disorders, inflammation, energy metabolism, host-microbe interactions, immune system, lipid accumulation, microbiota-targeted therapy, dysbiosis
MeSH terms
Gastrointestinal Microbiome, Animals, Energy Metabolism, Homeostasis, Humans, Inflammation, Metabolic Diseases, Obesity, Metabolic Syndrome, Host-Pathogen Interactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review